Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

including inhalers Symbicort, Breztri Aerosphere and Airsupra. The cap will be applicable for patients who are uninsured or underinsured. The announcement follows a similar move by rival company ...